DK0845998T3 - Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles - Google Patents
Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandlesInfo
- Publication number
- DK0845998T3 DK0845998T3 DK96929318T DK96929318T DK0845998T3 DK 0845998 T3 DK0845998 T3 DK 0845998T3 DK 96929318 T DK96929318 T DK 96929318T DK 96929318 T DK96929318 T DK 96929318T DK 0845998 T3 DK0845998 T3 DK 0845998T3
- Authority
- DK
- Denmark
- Prior art keywords
- patient
- treated
- specifically recognize
- containing antibodies
- drugs containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19531346A DE19531346A1 (de) | 1995-08-25 | 1995-08-25 | Arzneimittel zur Immuntherapie, enthaltend Antikörper, die spezifisch das MHCII-Antigen eines zu behandelnden Patienten erkennen |
PCT/EP1996/003733 WO1997007819A1 (de) | 1995-08-25 | 1996-08-23 | Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0845998T3 true DK0845998T3 (da) | 2002-02-11 |
Family
ID=7770409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96929318T DK0845998T3 (da) | 1995-08-25 | 1996-08-23 | Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles |
Country Status (8)
Country | Link |
---|---|
US (1) | US6294167B1 (da) |
EP (1) | EP0845998B1 (da) |
AT (1) | ATE208630T1 (da) |
DE (2) | DE19531346A1 (da) |
DK (1) | DK0845998T3 (da) |
ES (1) | ES2164914T3 (da) |
PT (1) | PT845998E (da) |
WO (1) | WO1997007819A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8296098A (en) * | 1997-07-08 | 1999-02-08 | Board Of Regents, The University Of Texas System | Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
DE19937264A1 (de) * | 1999-08-06 | 2001-02-15 | Deutsches Krebsforsch | F¶v¶-Antikörper-Konstrukte |
JP2003515323A (ja) * | 1999-11-18 | 2003-05-07 | オックスフォード バイオメディカ(ユーケイ)リミテッド | 抗 体 |
US20030082188A1 (en) * | 2001-10-11 | 2003-05-01 | Tso J. Yun | Treatment of prostate cancer by inhibitors of NCAM2 |
DE10261223A1 (de) * | 2002-12-20 | 2004-07-08 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Steigerung der Immunantwort durch Substanzen, welche die Funktion von Natürlichen Killerzellen beeinflussen |
DK1874821T3 (da) | 2005-04-26 | 2013-07-08 | Trion Pharma Gmbh | Kombination af antistoffer med glykokortikoider til behandling af kræft |
GB0509318D0 (en) * | 2005-05-06 | 2005-06-15 | Chiron Srl | TCR-independent activation of T cells |
GB0512225D0 (en) * | 2005-06-16 | 2005-07-27 | Univ Sheffield | Immunoglobulin molecules |
EP1820513A1 (en) | 2006-02-15 | 2007-08-22 | Trion Pharma Gmbh | Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
WO2008016431A2 (en) | 2006-07-29 | 2008-02-07 | Robert Lamar Bjork | Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
GB0803076D0 (en) * | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
EP2241576A1 (en) | 2009-04-17 | 2010-10-20 | Trion Pharma Gmbh | Use of trifunctional bispecific antibodies for the treatment of tumors associated with CD133+/EpCAM+ cancer stem cells |
RS61722B1 (sr) * | 2014-03-13 | 2021-05-31 | Univ Basel | Karbohidratni ligandi koji se vezuju na igm antitela protiv glikoproteina povezanog sa mijelinom |
BR112019010878A2 (pt) | 2016-11-29 | 2019-10-01 | Lindhofer Horst | combinação de anticorpos multifuncionais de redirecionamento de células t com moduladores de ponto de verificação imunológico e usos dos mesmos |
SG11201907299XA (en) | 2017-02-08 | 2019-09-27 | Dragonfly Therapeutics Inc | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
DK3582806T3 (da) | 2017-02-20 | 2023-09-11 | Dragonfly Therapeutics Inc | Proteiner, der binder her2, nkg2d og cd16 |
MX2020008336A (es) | 2018-02-08 | 2020-09-21 | Dragonfly Therapeutics Inc | Dominios variables de anticuerpos que se dirigen al receptor nkg2d. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3269354D1 (en) * | 1981-06-25 | 1986-04-03 | Univ Leland Stanford Junior | Allele specific immunotherapeutic method and dosage form |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
-
1995
- 1995-08-25 DE DE19531346A patent/DE19531346A1/de not_active Ceased
-
1996
- 1996-08-23 ES ES96929318T patent/ES2164914T3/es not_active Expired - Lifetime
- 1996-08-23 DK DK96929318T patent/DK0845998T3/da active
- 1996-08-23 DE DE59608213T patent/DE59608213D1/de not_active Expired - Lifetime
- 1996-08-23 EP EP96929318A patent/EP0845998B1/de not_active Expired - Lifetime
- 1996-08-23 AT AT96929318T patent/ATE208630T1/de active
- 1996-08-23 WO PCT/EP1996/003733 patent/WO1997007819A1/de active IP Right Grant
- 1996-08-23 US US09/029,369 patent/US6294167B1/en not_active Expired - Lifetime
- 1996-08-23 PT PT96929318T patent/PT845998E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EP0845998B1 (de) | 2001-11-14 |
EP0845998A1 (de) | 1998-06-10 |
DE19531346A1 (de) | 1997-02-27 |
PT845998E (pt) | 2002-04-29 |
US6294167B1 (en) | 2001-09-25 |
WO1997007819A1 (de) | 1997-03-06 |
DE59608213D1 (de) | 2001-12-20 |
ES2164914T3 (es) | 2002-03-01 |
ATE208630T1 (de) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0845998T3 (da) | Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles | |
HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
ATE196314T1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit | |
FI964681A (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
GB2301366B (en) | Antibodies against E-selectin | |
IL138424A (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
CY1107628T1 (el) | Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων | |
EP0671920A4 (en) | AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES. | |
PT724456E (pt) | Anticorpos contra cd4 | |
DK0914144T3 (da) | Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi | |
DK1053256T3 (da) | Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf | |
TR199801722T2 (xx) | Peptit imm�nojenler. | |
DE69709407T2 (de) | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen | |
NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
DK0858504T3 (da) | Diagnostiske midler mod og behandlinger af periodontale sygdomme | |
DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
DK0802924T3 (da) | Lægemiddel til forlænget immunsuppression og eliminering af tumorceller | |
IT1270618B (it) | Proteine ad attivita' antitumorale | |
EP0955366A4 (en) | ANTIGENIC PROTEIN FROM MALASSEZIA | |
WO2000001729A3 (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome | |
DK1039931T3 (da) | Multivalente rekombinante antistoffer til at behandle HRV infektioner | |
DE69827017D1 (de) | Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung | |
FR2694938B1 (fr) | Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant. | |
BR9611904A (pt) | Dioxidos de ditiazol | |
ATE209041T1 (de) | Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung |